ID ORC2_HUMAN Reviewed; 577 AA. AC Q13416; Q13204; Q53TX5; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 30-MAY-2000, sequence version 2. DT 27-MAR-2024, entry version 183. DE RecName: Full=Origin recognition complex subunit 2; GN Name=ORC2; Synonyms=ORC2L; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=7502077; DOI=10.1126/science.270.5242.1667; RA Gavin K.A., Hidaka M., Stillman B.D.; RT "Conserved initiator proteins in eukaryotes."; RL Science 270:1667-1671(1995). RN [2] RP SEQUENCE REVISION TO 41-42. RA Hidaka M., Stillman B.; RL Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=8808289; DOI=10.1006/geno.1996.0018; RA Takahara K., Bong M., Brevard R., Eddy R.L., Haley L.L., Sait S.J., RA Shows T.B., Hoffman G.G., Greenspan D.S.; RT "Mouse and human homologues of the yeast origin of replication recognition RT complex subunit ORC2 and chromosomal localization of the cognate human gene RT ORC2L."; RL Genomics 31:119-122(1996). RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-106 AND GLN-521. RG NIEHS SNPs program; RL Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., RA Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., RA Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., RA Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., RA Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., RA Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., RA Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., RA Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., RA Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., RA Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., RA Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., RA Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., RA Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., RA Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., RA Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., RA Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., RA Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 and RT 4."; RL Nature 434:724-731(2005). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Placenta; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP INTERACTION WITH MCM10. RX PubMed=11095689; DOI=10.1093/nar/28.23.4769; RA Izumi M., Yanagi K., Mizuno T., Yokoi M., Kawasaki Y., Moon K.Y., RA Hurwitz J., Yatagai F., Hanaoka F.; RT "The human homolog of Saccharomyces cerevisiae Mcm10 interacts with RT replication factors and dissociates from nuclease-resistant nuclear RT structures in G(2) phase."; RL Nucleic Acids Res. 28:4769-4777(2000). RN [9] RP IDENTIFICATION IN THE ORC COMPLEX, IDENTIFICATION BY MASS SPECTROMETRY, AND RP ASSEMBLY OF THE ORC COMPLEX. RX PubMed=12909626; DOI=10.1074/jbc.m307535200; RA Ohta S., Tatsumi Y., Fujita M., Tsurimoto T., Obuse C.; RT "The ORC1 cycle in human cells: II. Dynamic changes in the human ORC RT complex during the cell cycle."; RL J. Biol. Chem. 278:41535-41540(2003). RN [10] RP RECONSTITUTION OF THE ORC COMPLEX, AND DISASSEMBLY OF THE ORC COMPLEX. RX PubMed=17716973; DOI=10.1074/jbc.m705905200; RA Siddiqui K., Stillman B.; RT "ATP-dependent assembly of the human origin recognition complex."; RL J. Biol. Chem. 282:32370-32383(2007). RN [11] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-116 AND SER-280, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [12] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-116; SER-122; SER-138 AND RP THR-226, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). RN [13] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [14] RP FUNCTION, AND INTERACTION WITH LRWD1. RX PubMed=22935713; DOI=10.4161/cc.21870; RA Shen Z., Prasanth S.G.; RT "Orc2 protects ORCA from ubiquitin-mediated degradation."; RL Cell Cycle 11:3578-3589(2012). RN [15] RP FUNCTION, AND BINDING TO HISTONE H3 AND H4 TRIMETHYLATION MARKS. RX PubMed=22427655; DOI=10.1074/jbc.m111.337980; RA Chan K.M., Zhang Z.; RT "Leucine-rich repeat and WD repeat-containing protein 1 is recruited to RT pericentric heterochromatin by trimethylated lysine 9 of histone H3 and RT maintains heterochromatin silencing."; RL J. Biol. Chem. 287:15024-15033(2012). RN [16] RP INTERACTION WITH LRWD1. RX PubMed=22645314; DOI=10.1128/mcb.00362-12; RA Shen Z., Chakraborty A., Jain A., Giri S., Ha T., Prasanth K.V., RA Prasanth S.G.; RT "Dynamic association of ORCA with prereplicative complex components RT regulates DNA replication initiation."; RL Mol. Cell. Biol. 32:3107-3120(2012). RN [17] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-116; THR-226; SER-248 AND RP SER-280, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [18] RP INTERACTION WITH POLQ. RX PubMed=24989122; DOI=10.1038/ncomms5285; RA Fernandez-Vidal A., Guitton-Sert L., Cadoret J.C., Drac M., Schwob E., RA Baldacci G., Cazaux C., Hoffmann J.S.; RT "A role for DNA polymerase theta in the timing of DNA replication."; RL Nat. Commun. 5:4285-4285(2014). CC -!- FUNCTION: Component of the origin recognition complex (ORC) that binds CC origins of replication. DNA-binding is ATP-dependent. The specific DNA CC sequences that define origins of replication have not been identified CC yet. ORC is required to assemble the pre-replication complex necessary CC to initiate DNA replication. Binds histone H3 and H4 trimethylation CC marks H3K9me3, H3K20me3 and H4K27me3. Stabilizes LRWD1, by protecting CC it from ubiquitin-mediated proteasomal degradation. Also stabilizes CC ORC3. {ECO:0000269|PubMed:22427655, ECO:0000269|PubMed:22935713}. CC -!- SUBUNIT: Component of ORC, a complex composed of at least 6 subunits: CC ORC1, ORC2, ORC3, ORC4, ORC5 and ORC6. ORC is regulated in a cell-cycle CC dependent manner. It is sequentially assembled at the exit from CC anaphase of mitosis and disassembled as cells enter S phase CC (PubMed:12909626, PubMed:17716973). Interacts with DBF4 (By CC similarity). Interacts with MCM10 (PubMed:11095689). Interacts with CC LRWD1 throughout the cell cycle; this interaction, wich occurs only CC with non-ubiquitinated form of LRWD1, prevents LRWD1 ubiquitination and CC hence stabilizes the protein (PubMed:22645314). Interacts with POLQ CC (PubMed:24989122). {ECO:0000250|UniProtKB:Q60862, CC ECO:0000269|PubMed:11095689, ECO:0000269|PubMed:12909626, CC ECO:0000269|PubMed:17716973, ECO:0000269|PubMed:22645314, CC ECO:0000269|PubMed:22935713}. CC -!- INTERACTION: CC Q13416; Q99459: CDC5L; NbExp=2; IntAct=EBI-374957, EBI-374880; CC Q13416; Q9UI47-2: CTNNA3; NbExp=3; IntAct=EBI-374957, EBI-11962928; CC Q13416; Q08050: FOXM1; NbExp=2; IntAct=EBI-374957, EBI-866480; CC Q13416; Q7L590: MCM10; NbExp=5; IntAct=EBI-374957, EBI-374912; CC Q13416; P25205: MCM3; NbExp=2; IntAct=EBI-374957, EBI-355153; CC Q13416; Q13415: ORC1; NbExp=14; IntAct=EBI-374957, EBI-374847; CC Q13416; Q9UBD5: ORC3; NbExp=28; IntAct=EBI-374957, EBI-374916; CC Q13416; O43929: ORC4; NbExp=12; IntAct=EBI-374957, EBI-374889; CC Q13416; O43913: ORC5; NbExp=15; IntAct=EBI-374957, EBI-374928; CC Q13416; Q9NS91: RAD18; NbExp=3; IntAct=EBI-374957, EBI-2339393; CC Q13416; P57055: RIPPLY3; NbExp=3; IntAct=EBI-374957, EBI-12092053; CC Q13416; Q15554: TERF2; NbExp=3; IntAct=EBI-374957, EBI-706637; CC Q13416; P03211: EBNA1; Xeno; NbExp=6; IntAct=EBI-374957, EBI-996522; CC -!- SUBCELLULAR LOCATION: Nucleus. CC -!- SIMILARITY: Belongs to the ORC2 family. {ECO:0000305}. CC -!- WEB RESOURCE: Name=NIEHS-SNPs; CC URL="http://egp.gs.washington.edu/data/orc2l/"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U40268; AAC50326.2; -; mRNA. DR EMBL; U27459; AAB33970.1; -; mRNA. DR EMBL; AY652588; AAT46690.1; -; Genomic_DNA. DR EMBL; AC005037; AAY14725.1; -; Genomic_DNA. DR EMBL; CH471063; EAW70228.1; -; Genomic_DNA. DR EMBL; BC014834; AAH14834.1; -; mRNA. DR CCDS; CCDS2334.1; -. DR RefSeq; NP_006181.1; NM_006190.4. DR RefSeq; XP_006712618.1; XM_006712555.3. DR PDB; 5C8H; X-ray; 2.01 A; A=458-577. DR PDB; 5UJ8; X-ray; 6.00 A; E/F/G/H=231-577. DR PDB; 5UJM; EM; 18.00 A; B=231-577. DR PDB; 7CTE; EM; 3.80 A; B=1-577. DR PDB; 7CTF; EM; 4.80 A; B=1-577. DR PDB; 7CTG; EM; 5.00 A; B=1-577. DR PDB; 7JPO; EM; 3.20 A; B=1-577. DR PDB; 7JPP; EM; 3.70 A; B=1-577. DR PDB; 7JPQ; EM; 3.50 A; B=1-577. DR PDB; 7JPR; EM; 4.00 A; B=1-577. DR PDB; 7JPS; EM; 4.40 A; B=1-577. DR PDBsum; 5C8H; -. DR PDBsum; 5UJ8; -. DR PDBsum; 5UJM; -. DR PDBsum; 7CTE; -. DR PDBsum; 7CTF; -. DR PDBsum; 7CTG; -. DR PDBsum; 7JPO; -. DR PDBsum; 7JPP; -. DR PDBsum; 7JPQ; -. DR PDBsum; 7JPR; -. DR PDBsum; 7JPS; -. DR AlphaFoldDB; Q13416; -. DR EMDB; EMD-22417; -. DR EMDB; EMD-22418; -. DR EMDB; EMD-22419; -. DR EMDB; EMD-22420; -. DR EMDB; EMD-22421; -. DR EMDB; EMD-30462; -. DR EMDB; EMD-30463; -. DR EMDB; EMD-30464; -. DR SMR; Q13416; -. DR BioGRID; 111041; 104. DR ComplexPortal; CPX-1880; Nuclear origin recognition complex. DR CORUM; Q13416; -. DR DIP; DIP-29689N; -. DR ELM; Q13416; -. DR IntAct; Q13416; 49. DR MINT; Q13416; -. DR STRING; 9606.ENSP00000234296; -. DR GlyGen; Q13416; 2 sites, 1 O-linked glycan (2 sites). DR iPTMnet; Q13416; -. DR PhosphoSitePlus; Q13416; -. DR BioMuta; ORC2; -. DR DMDM; 8488999; -. DR EPD; Q13416; -. DR jPOST; Q13416; -. DR MassIVE; Q13416; -. DR MaxQB; Q13416; -. DR PaxDb; 9606-ENSP00000234296; -. DR PeptideAtlas; Q13416; -. DR ProteomicsDB; 59395; -. DR Pumba; Q13416; -. DR Antibodypedia; 34131; 254 antibodies from 37 providers. DR DNASU; 4999; -. DR Ensembl; ENST00000234296.7; ENSP00000234296.2; ENSG00000115942.9. DR GeneID; 4999; -. DR KEGG; hsa:4999; -. DR MANE-Select; ENST00000234296.7; ENSP00000234296.2; NM_006190.5; NP_006181.1. DR UCSC; uc002uwr.4; human. DR AGR; HGNC:8488; -. DR CTD; 4999; -. DR DisGeNET; 4999; -. DR GeneCards; ORC2; -. DR HGNC; HGNC:8488; ORC2. DR HPA; ENSG00000115942; Low tissue specificity. DR MIM; 601182; gene. DR neXtProt; NX_Q13416; -. DR OpenTargets; ENSG00000115942; -. DR PharmGKB; PA32809; -. DR VEuPathDB; HostDB:ENSG00000115942; -. DR eggNOG; KOG2928; Eukaryota. DR GeneTree; ENSGT00390000015228; -. DR HOGENOM; CLU_018596_3_0_1; -. DR InParanoid; Q13416; -. DR OMA; AHERYFF; -. DR OrthoDB; 9018at2759; -. DR PhylomeDB; Q13416; -. DR TreeFam; TF101092; -. DR BRENDA; 3.6.4.B8; 2681. DR PathwayCommons; Q13416; -. DR Reactome; R-HSA-113507; E2F-enabled inhibition of pre-replication complex formation. DR Reactome; R-HSA-176187; Activation of ATR in response to replication stress. DR Reactome; R-HSA-68616; Assembly of the ORC complex at the origin of replication. DR Reactome; R-HSA-68689; CDC6 association with the ORC:origin complex. DR Reactome; R-HSA-68867; Assembly of the pre-replicative complex. DR Reactome; R-HSA-68949; Orc1 removal from chromatin. DR Reactome; R-HSA-68962; Activation of the pre-replicative complex. DR SignaLink; Q13416; -. DR SIGNOR; Q13416; -. DR BioGRID-ORCS; 4999; 70 hits in 1163 CRISPR screens. DR ChiTaRS; ORC2; human. DR GeneWiki; ORC2; -. DR GeneWiki; ORC2L; -. DR GenomeRNAi; 4999; -. DR Pharos; Q13416; Tbio. DR PRO; PR:Q13416; -. DR Proteomes; UP000005640; Chromosome 2. DR RNAct; Q13416; Protein. DR Bgee; ENSG00000115942; Expressed in calcaneal tendon and 177 other cell types or tissues. DR ExpressionAtlas; Q13416; baseline and differential. DR GO; GO:0005813; C:centrosome; IDA:CACAO. DR GO; GO:0000781; C:chromosome, telomeric region; HDA:BHF-UCL. DR GO; GO:0000792; C:heterochromatin; IDA:CACAO. DR GO; GO:0000939; C:inner kinetochore; IEA:Ensembl. DR GO; GO:0016020; C:membrane; HDA:UniProtKB. DR GO; GO:0005664; C:nuclear origin of replication recognition complex; IDA:UniProtKB. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0000808; C:origin recognition complex; IDA:UniProtKB. DR GO; GO:0003688; F:DNA replication origin binding; IBA:GO_Central. DR GO; GO:0006270; P:DNA replication initiation; IDA:ComplexPortal. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; TAS:ProtInc. DR InterPro; IPR007220; ORC2. DR PANTHER; PTHR14052; ORIGIN RECOGNITION COMPLEX SUBUNIT 2; 1. DR PANTHER; PTHR14052:SF0; ORIGIN RECOGNITION COMPLEX SUBUNIT 2; 1. DR Pfam; PF04084; ORC2; 1. DR Genevisible; Q13416; HS. PE 1: Evidence at protein level; KW 3D-structure; DNA replication; Nucleus; Phosphoprotein; Reference proteome. FT CHAIN 1..577 FT /note="Origin recognition complex subunit 2" FT /id="PRO_0000127075" FT REPEAT 1..100 FT /note="Involved in LRWD1-binding" FT REGION 81..199 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 81..97 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 115..146 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 116 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163" FT MOD_RES 122 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:20068231" FT MOD_RES 138 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:20068231" FT MOD_RES 226 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:20068231, FT ECO:0007744|PubMed:23186163" FT MOD_RES 248 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 280 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:23186163" FT VARIANT 106 FT /note="M -> K (in dbSNP:rs2307361)" FT /evidence="ECO:0000269|Ref.4" FT /id="VAR_014515" FT VARIANT 521 FT /note="R -> Q (in dbSNP:rs16835624)" FT /evidence="ECO:0000269|Ref.4" FT /id="VAR_021276" FT CONFLICT 131 FT /note="I -> V (in Ref. 3; AAB33970)" FT /evidence="ECO:0000305" FT CONFLICT 236 FT /note="T -> L (in Ref. 3; AAB33970)" FT /evidence="ECO:0000305" FT CONFLICT 392 FT /note="I -> M (in Ref. 3; AAB33970)" FT /evidence="ECO:0000305" FT HELIX 240..247 FT /evidence="ECO:0007829|PDB:7JPO" FT HELIX 271..275 FT /evidence="ECO:0007829|PDB:7JPO" FT HELIX 284..288 FT /evidence="ECO:0007829|PDB:7JPO" FT TURN 289..291 FT /evidence="ECO:0007829|PDB:7JPO" FT TURN 294..297 FT /evidence="ECO:0007829|PDB:7JPO" FT HELIX 298..306 FT /evidence="ECO:0007829|PDB:7JPO" FT STRAND 310..314 FT /evidence="ECO:0007829|PDB:7JPO" FT HELIX 320..329 FT /evidence="ECO:0007829|PDB:7JPO" FT STRAND 332..339 FT /evidence="ECO:0007829|PDB:7JPO" FT STRAND 343..345 FT /evidence="ECO:0007829|PDB:7JPQ" FT HELIX 348..358 FT /evidence="ECO:0007829|PDB:7JPO" FT HELIX 369..382 FT /evidence="ECO:0007829|PDB:7JPO" FT STRAND 388..393 FT /evidence="ECO:0007829|PDB:7JPO" FT STRAND 395..397 FT /evidence="ECO:0007829|PDB:7JPO" FT TURN 398..400 FT /evidence="ECO:0007829|PDB:7JPO" FT HELIX 403..413 FT /evidence="ECO:0007829|PDB:7JPO" FT STRAND 418..424 FT /evidence="ECO:0007829|PDB:7JPO" FT HELIX 429..432 FT /evidence="ECO:0007829|PDB:7JPO" FT TURN 435..440 FT /evidence="ECO:0007829|PDB:7JPO" FT STRAND 443..447 FT /evidence="ECO:0007829|PDB:7JPO" FT TURN 456..463 FT /evidence="ECO:0007829|PDB:7JPO" FT STRAND 464..466 FT /evidence="ECO:0007829|PDB:7JPQ" FT STRAND 469..472 FT /evidence="ECO:0007829|PDB:7JPQ" FT HELIX 474..481 FT /evidence="ECO:0007829|PDB:5C8H" FT HELIX 486..501 FT /evidence="ECO:0007829|PDB:5C8H" FT TURN 502..504 FT /evidence="ECO:0007829|PDB:5C8H" FT HELIX 513..522 FT /evidence="ECO:0007829|PDB:5C8H" FT HELIX 529..541 FT /evidence="ECO:0007829|PDB:5C8H" FT STRAND 546..549 FT /evidence="ECO:0007829|PDB:5C8H" FT STRAND 555..558 FT /evidence="ECO:0007829|PDB:5C8H" FT HELIX 563..572 FT /evidence="ECO:0007829|PDB:5C8H" SQ SEQUENCE 577 AA; 65972 MW; DF3F9C2CF147DA5F CRC64; MSKPELKEDK MLEVHFVGDD DVLNHILDRE GGAKLKKERA QLLVNPKKII KKPEYDLEED DQEVLKDQNY VEIMGRDVQE SLKNGSATGG GNKVYSFQNR KHSEKMAKLA SELAKTPQKS VSFSLKNDPE ITINVPQSSK GHSASDKVQP KNNDKSEFLS TAPRSLRKRL IVPRSHSDSE SEYSASNSED DEGVAQEHEE DTNAVIFSQK IQAQNRVVSA PVGKETPSKR MKRDKTSDLV EEYFEAHSSS KVLTSDRTLQ KLKRAKLDQQ TLRNLLSKVS PSFSAELKQL NQQYEKLFHK WMLQLHLGFN IVLYGLGSKR DLLERFRTTM LQDSIHVVIN GFFPGISVKS VLNSITEEVL DHMGTFRSIL DQLDWIVNKF KEDSSLELFL LIHNLDSQML RGEKSQQIIG QLSSLHNIYL IASIDHLNAP LMWDHAKQSL FNWLWYETTT YSPYTEETSY ENSLLVKQSG SLPLSSLTHV LRSLTPNARG IFRLLIKYQL DNQDNPSYIG LSFQDFYQQC REAFLVNSDL TLRAQLTEFR DHKLIRTKKG TDGVEYLLIP VDNGTLTDFL EKEEEEA //